Serial Number:
79280774
Mark:
ZELIRA
Status:
Registered
Status Date:
03-01-2022
Filing Date:
Registration Number:
6655611
Registration Date:
03-01-2022
Preparations for medical purposes derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, terminal illnesses, epilepsy, arthritis, crohn's disease, insomnia, diabetes, eczema, psychiatric diseases and disorders including mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder; none of the foregoing being preparations to treat deficiencies of Alpha-One proteinase inhibitors; none of the goods being for the treatment and detection of cervical cancer and related infections Conducting clinical trials for others; research relating to science; provision of pharmaceutical research services; project management and planning of clinical trials, namely, consulting services for others in the field of design, planning, and implementation project management of clinical trials; research relating to pharmaceuticals; research relating to medicinal use of marijuana and cannabis; scientific research relating to medicinal use of cannabis; scientific research and development of medicinal cannabis products; medical research; scientific research for medical purposes; scientific research; none of the foregoing in relation to the treatment of deficiencies of Alpha-One proteinase inhibitors; none of the services being for the treatment and detection of cervical cancer and related infections
Mark Description:
N/A
Class:
Scientific and technological services
Type of Mark:
Trademark
Published for Opposition Date:
12-14-2021
Owner:
Mark Drawing Status:
Standart Character Mark
Abandon Date:
N/A
Business Name:
STRADLEY RONON STEVENS & YOUNG, LLP
Correspondent Name:
